MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

LifeCell International transforms DNA screening for newborns with RightStart

LifeCell International transforms DNA screening for newborns with RightStart

India’s first and largest stem cell bank, LifeCell International, has recently launched its integrated DNA testing that would detect more than 50 medical conditions.Names as ‘RightStart’, it will be used for Newborn Screening. The technology offers more accuracy than the current screening methods, while also reducing the false-positive reporting and eliminating the unnecessary follow-up tests and anxiety of parents in the process.

The current procedure of newborn screening involves takinga couple of drops of blood from the baby’s heel after 48 hours of its birth that is later analysed by profiling a specific set of metabolites present in the blood. Further testing is conducted in the presence of any abnormal metabolic profile just for confirmation. Extra blood samples are also collected from the child for the confirmatory test. Generally, most of the routine screening labs lack adequate DNA testing abilities, and the child has to be sent to specialised labs causing vexatious delays in diagnostics and treatment.The DNA based test is viewed as the highest standard as it offers better reliability for confirmation, andinterferences like medications, nutrition, temperature have no effect on it.

But the integrated DNA testing approach that is adopted in RightStart Newborn screening can work without any additional sample since it will use a portion of the sample already collected. This would also eliminate extra expenses incurred by the parents. It gives precise outcomes and further enables a quick diagnosis to initiate treatment.

YOU MAY ALSO LIKE

Tariff plans will cost higher from the next financial year as telecom companies are gearing up to increase rates

The ongoing Covid pandemic had significantly increased the number of mobile and internet users worldwide. The high amount of usage is expected to drop...

Business Travelers to Stay at Singapore’s Changi Airport Bubble

Singapore’s open economy depends heavily on tourism and business. But its vibrant but small economy has been hurting as the circumstances due to...

Countries in Asia-Pacific are marching towards ‘green recovery’ amidst Covid-19 crisis

2020 has been an unforgettable year for many of us. The ongoing Covid crisis has reminded people that it is very important to have an uninterrupted an...

Department of Telecommunication to announce the new schedule for 5G trials

Department of Telecommunications (DoT) is all set to announce the new schedule for 5G trials. The Dot made this decision after being pulled by the par...

RECOMMENDED